RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yasuhiro Yamauchi to Lung

This is a "connection" page, showing publications Yasuhiro Yamauchi has written about Lung.
Connection Strength

1.763
  1. Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:1403-11.
    View in: PubMed
    Score: 0.445
  2. Ikeda T, Yamauchi Y, Uchida K, Oba K, Nagase T, Yamada Y. Reference value for expiratory time constant calculated from the maximal expiratory flow-volume curve. BMC Pulm Med. 2019 Nov 11; 19(1):208.
    View in: PubMed
    Score: 0.141
  3. Urushiyama H, Terasaki Y, Nagasaka S, Kokuho N, Endo Y, Terasaki M, Kunugi S, Makita K, Isago H, Hosoki K, Souma K, Ishii T, Matsuzaki H, Hiraishi Y, Mikami Y, Noguchi S, Tamiya H, Mitani A, Yamauchi Y, Shimizu A, Nagase T. Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice. J Cell Mol Med. 2019 05; 23(5):3563-3571.
    View in: PubMed
    Score: 0.134
  4. Jo T, Michihata N, Yamana H, Sasabuchi Y, Matsui H, Urushiyama H, Mitani A, Yamauchi Y, Fushimi K, Nagase T, Yasunaga H. Reduction in exacerbation of COPD in patients of advanced age using the Japanese Kampo medicine Dai-kenchu-to: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2019; 14:129-139.
    View in: PubMed
    Score: 0.133
  5. Takeshima H, Horie M, Mikami Y, Makita K, Miyashita N, Matsuzaki H, Noguchi S, Urushiyama H, Hiraishi Y, Mitani A, Borok Z, Nagase T, Yamauchi Y. CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts. Allergol Int. 2019 Jan; 68(1):101-109.
    View in: PubMed
    Score: 0.130
  6. Yokoyama A, Kage H, Ohama Y, Sato T, Miyashita N, Noguchi S, Okugawa S, Yamauchi Y, Moriya K, Nagase T. Mycobacterium heckeshornense lung infection diagnosed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). J Infect Chemother. 2018 Sep; 24(9):763-765.
    View in: PubMed
    Score: 0.125
  7. Horie M, Miyashita N, Mikami Y, Noguchi S, Yamauchi Y, Suzukawa M, Fukami T, Ohta K, Asano Y, Sato S, Yamaguchi Y, Ohshima M, Suzuki HI, Saito A, Nagase T. TBX4 is involved in the super-enhancer-driven transcriptional programs underlying features specific to lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2018 01 01; 314(1):L177-L191.
    View in: PubMed
    Score: 0.122
  8. Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017; 12:1605-1611.
    View in: PubMed
    Score: 0.119
  9. Noguchi S, Yamauchi Y, Takizawa H. Novel therapeutic strategies for fibrotic lung disease: a review with a focus on epithelial-mesenchymal transition. Recent Pat Inflamm Allergy Drug Discov. 2014 Jan; 8(1):9-18.
    View in: PubMed
    Score: 0.094
  10. Kohyama T, Yamauchi Y, Takizawa H, Itakura S, Kamitani S, Desaki M, Kawasaki S, Nagase T. Procaterol inhibits lung fibroblast migration. Inflammation. 2009 Dec; 32(6):387-92.
    View in: PubMed
    Score: 0.071
  11. Kohyama T, Yamauchi Y, Takizawa H, Kamitani S, Kawasaki S, Nagase T. Histamine stimulates human lung fibroblast migration. Mol Cell Biochem. 2010 Apr; 337(1-2):77-81.
    View in: PubMed
    Score: 0.070
  12. Kikuchi K, Kohyama T, Yamauchi Y, Kato J, Takami K, Okazaki H, Desaki M, Nagase T, Rennard SI, Takizawa H. C-reactive protein modulates human lung fibroblast migration. Exp Lung Res. 2009 Feb; 35(1):48-58.
    View in: PubMed
    Score: 0.067
  13. Li YJ, Kawada T, Takizawa H, Azuma A, Kudoh S, Sugawara I, Yamauchi Y, Kohyama T. Airway inflammatory responses to oxidative stress induced by prolonged low-dose diesel exhaust particle exposure from birth differ between mouse BALB/c and C57BL/6 strains. Exp Lung Res. 2008 Mar; 34(3):125-39.
    View in: PubMed
    Score: 0.063
  14. Li YJ, Takizawa H, Azuma A, Kohyama T, Yamauchi Y, Takahashi S, Yamamoto M, Kawada T, Kudoh S, Sugawara I. Nrf2 is closely related to allergic airway inflammatory responses induced by low-dose diesel exhaust particles in mice. Clin Immunol. 2010 Nov; 137(2):234-41.
    View in: PubMed
    Score: 0.019
  15. Kohyama T, Yamauchi Y, Takizawa H, Itakura S, Kamitani S, Kato J, Nagase T. Clarithromycin inhibits fibroblast migration. Respir Med. 2008 Dec; 102(12):1769-76.
    View in: PubMed
    Score: 0.016
  16. Li YJ, Takizawa H, Azuma A, Kohyama T, Yamauchi Y, Takahashi S, Yamamoto M, Kawada T, Kudoh S, Sugawara I. Disruption of Nrf2 enhances susceptibility to airway inflammatory responses induced by low-dose diesel exhaust particles in mice. Clin Immunol. 2008 Sep; 128(3):366-73.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support